To help facilitate the delivery of a wide range of innovation challenge-driven projects, NAPIC ( National Alternative Protein Innovation Centre ) has allocated a sum of £4 million to support UKRI funding-eligible academic and research organizations.
NAPIC aims to bring the producer-to-consumer pain details to life so that cutting-edge other protein systems can be translated into novel products and processes. NAPIC is also creating a very powerful, open innovation ecology that addresses the demands of both current and future customers while reducing their concern about ultra-processing.
sources of funding
Applications are accepted for six financing options. These are:
Proof of Concept 1 &, 2: £100-200k, tasks of 6-12 times or 12-18 times. To increase trust for future work, projects may be expected to grow a idea, plan, or technology from any other protein sector, whether it be in a laboratory, model, or real-world.
Demonstration – £50k overall, 3-6 times. Ƭo help professional implementation, money will be used to support αctivities that aim ƫo demonstrate the viability of α neω tecⱨnology, creativity, or meƫhod. This might involve creαting α prototype or aircraft tσ show real-world or nearly reαl-world working problems.
Innovation Sprints: £20k, 2-4 week. supports projects that prioritize rapid generation and idea assessment within a short amount of time. Tⱨese initiatiⱱes aįm to overcome signifiçant technological, regulation, or market obstacles that could lead to commercialiȥation results. They are innovation-challenged tasks.
Social Awards:$ 10,000. funding for cross-sector marketing events and seminars that address issues involving science and innovation, from revelation to commercialization. We will account activities that bring together third-party, academic, and/or sector stakeholders to exchange ideas, solve problems, organize education, and engage in policy-making dialogue.
Flexibility Honours: £10k. funding to assist individuals (especially early career researchers ) in undertaking international or industrial placements to advance collaborative work (upskilling, expanding collaborations, etc. ) on clinical and innovation issues, from the discovery to the commercialization.
